TABLE 4.
The analysis outcomes of FBG 04 in the high-dosage group in study 2.
| Critical values (mmol/L) | Reached (n) | HbA1c012>0% (n) | Percentage (%) |
|---|---|---|---|
| 0.1 | 46 | 41 | 89.1 |
| 0.2 | 43 | 38 | 88.4 |
| 0.3 | 37 | 34 | 91.9 a |
| 0.4 | 34 | 33 | 97.1 a |
| 0.5 | 32 | 31 | 96.9 a |
| 0.6 | 38 | 29 | 96.7 a |
| 0.7 | 26 | 25 | 96.2 a |
| 0.8 | 24 | 23 | 95.8 a |
| 0.9 | 20 | 19 | 95.0 |
| 1.0 | 18 | 17 | 94.4 |
| 1.1 | 15 | 14 | 93.3 |
Significant at p < 0.05.0.3 mmol/L was the first percentage more than 85% at p < 0.05.